- Home
- BH vs IVA Comparison
BH vs IVA Comparison
Compare BH & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BH
- IVA
- Stock Information
- Founded
- BH 1934
- IVA 2011
- Country
- BH United States
- IVA France
- Employees
- BH N/A
- IVA N/A
- Industry
- BH Restaurants
- IVA Biotechnology: Pharmaceutical Preparations
- Sector
- BH Consumer Discretionary
- IVA Health Care
- Exchange
- BH Nasdaq
- IVA Nasdaq
- Market Cap
- BH 904.4M
- IVA 769.0M
- IPO Year
- BH N/A
- IVA 2020
- Fundamental
- Price
- BH $316.55
- IVA $5.77
- Analyst Decision
- BH
- IVA Strong Buy
- Analyst Count
- BH 0
- IVA 6
- Target Price
- BH N/A
- IVA $15.33
- AVG Volume (30 Days)
- BH 24.1K
- IVA 71.5K
- Earning Date
- BH 11-07-2025
- IVA 09-26-2025
- Dividend Yield
- BH N/A
- IVA N/A
- EPS Growth
- BH N/A
- IVA N/A
- EPS
- BH 146.55
- IVA N/A
- Revenue
- BH $377,176,000.00
- IVA $14,591,573.00
- Revenue This Year
- BH N/A
- IVA $80.35
- Revenue Next Year
- BH N/A
- IVA N/A
- P/E Ratio
- BH $23.99
- IVA N/A
- Revenue Growth
- BH 4.14
- IVA N/A
- 52 Week Low
- BH $159.69
- IVA $1.53
- 52 Week High
- BH $328.65
- IVA $6.50
- Technical
- Relative Strength Index (RSI)
- BH 58.22
- IVA 63.84
- Support Level
- BH $303.46
- IVA $5.21
- Resistance Level
- BH $317.15
- IVA $5.75
- Average True Range (ATR)
- BH 10.35
- IVA 0.37
- MACD
- BH 0.07
- IVA -0.01
- Stochastic Oscillator
- BH 80.99
- IVA 67.26
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.